nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—migraine—Prednisone—chronic obstructive pulmonary disease	0.651	1	CpDpCtD
Orphenadrine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0781	0.339	CbGbCtD
Orphenadrine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.057	0.248	CbGbCtD
Orphenadrine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0268	0.116	CbGbCtD
Orphenadrine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0181	0.0786	CbGbCtD
Orphenadrine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0173	0.075	CbGbCtD
Orphenadrine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0154	0.0669	CbGbCtD
Orphenadrine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00903	0.0392	CbGbCtD
Orphenadrine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00853	0.037	CbGbCtD
Orphenadrine—Gastric irritation—Aminophylline—chronic obstructive pulmonary disease	0.00551	0.065	CcSEcCtD
Orphenadrine—Epigastric discomfort—Aminophylline—chronic obstructive pulmonary disease	0.00406	0.048	CcSEcCtD
Orphenadrine—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.0227	CcSEcCtD
Orphenadrine—Gastric irritation—Prednisone—chronic obstructive pulmonary disease	0.00165	0.0195	CcSEcCtD
Orphenadrine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00137	0.0162	CcSEcCtD
Orphenadrine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.0155	CcSEcCtD
Orphenadrine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.0146	CcSEcCtD
Orphenadrine—Epigastric discomfort—Prednisone—chronic obstructive pulmonary disease	0.00122	0.0144	CcSEcCtD
Orphenadrine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.0131	CcSEcCtD
Orphenadrine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.013	CcSEcCtD
Orphenadrine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000977	0.0115	CcSEcCtD
Orphenadrine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000942	0.0111	CcSEcCtD
Orphenadrine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000916	0.0108	CcSEcCtD
Orphenadrine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000908	0.0107	CcSEcCtD
Orphenadrine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000891	0.0105	CcSEcCtD
Orphenadrine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000875	0.0103	CcSEcCtD
Orphenadrine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000859	0.0101	CcSEcCtD
Orphenadrine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000858	0.0101	CcSEcCtD
Orphenadrine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000842	0.00994	CcSEcCtD
Orphenadrine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00083	0.0098	CcSEcCtD
Orphenadrine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000825	0.00974	CcSEcCtD
Orphenadrine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.00968	CcSEcCtD
Orphenadrine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000796	0.00939	CcSEcCtD
Orphenadrine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000778	0.00919	CcSEcCtD
Orphenadrine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000762	0.009	CcSEcCtD
Orphenadrine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000756	0.00892	CcSEcCtD
Orphenadrine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000744	0.00878	CcSEcCtD
Orphenadrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000727	0.00858	CcSEcCtD
Orphenadrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000716	0.00845	CcSEcCtD
Orphenadrine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000701	0.00828	CcSEcCtD
Orphenadrine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000698	0.00824	CcSEcCtD
Orphenadrine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00823	CcSEcCtD
Orphenadrine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00823	CcSEcCtD
Orphenadrine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000679	0.00801	CcSEcCtD
Orphenadrine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000666	0.00786	CcSEcCtD
Orphenadrine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000666	0.00786	CcSEcCtD
Orphenadrine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.00777	CcSEcCtD
Orphenadrine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00771	CcSEcCtD
Orphenadrine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00771	CcSEcCtD
Orphenadrine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000652	0.0077	CcSEcCtD
Orphenadrine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00064	0.00755	CcSEcCtD
Orphenadrine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00742	CcSEcCtD
Orphenadrine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000628	0.00742	CcSEcCtD
Orphenadrine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.00742	CcSEcCtD
Orphenadrine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00728	CcSEcCtD
Orphenadrine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000615	0.00726	CcSEcCtD
Orphenadrine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000615	0.00726	CcSEcCtD
Orphenadrine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000605	0.00715	CcSEcCtD
Orphenadrine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.007	CcSEcCtD
Orphenadrine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00685	CcSEcCtD
Orphenadrine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00685	CcSEcCtD
Orphenadrine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.00674	CcSEcCtD
Orphenadrine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000568	0.00671	CcSEcCtD
Orphenadrine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000566	0.00668	CcSEcCtD
Orphenadrine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000566	0.00668	CcSEcCtD
Orphenadrine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000563	0.00665	CcSEcCtD
Orphenadrine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000563	0.00665	CcSEcCtD
Orphenadrine—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.000562	0.105	CrCbGaD
Orphenadrine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000561	0.00663	CcSEcCtD
Orphenadrine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000552	0.00652	CcSEcCtD
Orphenadrine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00647	CcSEcCtD
Orphenadrine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.00637	CcSEcCtD
Orphenadrine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000535	0.00631	CcSEcCtD
Orphenadrine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000532	0.00628	CcSEcCtD
Orphenadrine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00053	0.00625	CcSEcCtD
Orphenadrine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00609	CcSEcCtD
Orphenadrine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00609	CcSEcCtD
Orphenadrine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.006	CcSEcCtD
Orphenadrine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000505	0.00596	CcSEcCtD
Orphenadrine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00595	CcSEcCtD
Orphenadrine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000496	0.00586	CcSEcCtD
Orphenadrine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.00586	CcSEcCtD
Orphenadrine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00575	CcSEcCtD
Orphenadrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000485	0.00572	CcSEcCtD
Orphenadrine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00564	CcSEcCtD
Orphenadrine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00564	CcSEcCtD
Orphenadrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000477	0.00564	CcSEcCtD
Orphenadrine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00561	CcSEcCtD
Orphenadrine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00553	CcSEcCtD
Orphenadrine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00544	CcSEcCtD
Orphenadrine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00544	CcSEcCtD
Orphenadrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000457	0.0054	CcSEcCtD
Orphenadrine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000453	0.00534	CcSEcCtD
Orphenadrine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00533	CcSEcCtD
Orphenadrine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00533	CcSEcCtD
Orphenadrine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.00532	CcSEcCtD
Orphenadrine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00514	CcSEcCtD
Orphenadrine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00505	CcSEcCtD
Orphenadrine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00505	CcSEcCtD
Orphenadrine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.00504	CcSEcCtD
Orphenadrine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00494	CcSEcCtD
Orphenadrine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00491	CcSEcCtD
Orphenadrine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00491	CcSEcCtD
Orphenadrine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00484	CcSEcCtD
Orphenadrine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00484	CcSEcCtD
Orphenadrine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00481	CcSEcCtD
Orphenadrine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00476	CcSEcCtD
Orphenadrine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00475	CcSEcCtD
Orphenadrine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00464	CcSEcCtD
Orphenadrine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.00457	CcSEcCtD
Orphenadrine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00453	CcSEcCtD
Orphenadrine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00453	CcSEcCtD
Orphenadrine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00444	CcSEcCtD
Orphenadrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00435	CcSEcCtD
Orphenadrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00435	CcSEcCtD
Orphenadrine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00429	CcSEcCtD
Orphenadrine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00429	CcSEcCtD
Orphenadrine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.00428	CcSEcCtD
Orphenadrine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00428	CcSEcCtD
Orphenadrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00426	CcSEcCtD
Orphenadrine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000356	0.0042	CcSEcCtD
Orphenadrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00411	CcSEcCtD
Orphenadrine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00407	CcSEcCtD
Orphenadrine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00407	CcSEcCtD
Orphenadrine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00405	CcSEcCtD
Orphenadrine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00398	CcSEcCtD
Orphenadrine—Reboxetine—SLC6A4—chronic obstructive pulmonary disease	0.000329	0.0616	CrCbGaD
Orphenadrine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00384	CcSEcCtD
Orphenadrine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00377	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00371	CcSEcCtD
Orphenadrine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.00362	CcSEcCtD
Orphenadrine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00311	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00306	CcSEcCtD
Orphenadrine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00303	CcSEcCtD
Orphenadrine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00295	CcSEcCtD
Orphenadrine—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.000246	0.0461	CrCbGaD
Orphenadrine—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.000238	0.0445	CrCbGaD
Orphenadrine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00273	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000228	0.0027	CcSEcCtD
Orphenadrine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00263	CcSEcCtD
Orphenadrine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00262	CcSEcCtD
Orphenadrine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00245	CcSEcCtD
Orphenadrine—Fluoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000206	0.0386	CrCbGaD
Orphenadrine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000205	0.0384	CrCbGaD
Orphenadrine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00232	CcSEcCtD
Orphenadrine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000195	0.0023	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00222	CcSEcCtD
Orphenadrine—Fluoxetine—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.0352	CrCbGaD
Orphenadrine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.0022	CcSEcCtD
Orphenadrine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00214	CcSEcCtD
Orphenadrine—Warfarin—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.0332	CrCbGaD
Orphenadrine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000173	0.0324	CrCbGaD
Orphenadrine—Warfarin—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.0321	CrCbGaD
Orphenadrine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00199	CcSEcCtD
Orphenadrine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00193	CcSEcCtD
Orphenadrine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00191	CcSEcCtD
Orphenadrine—Fluoxetine—HTR2A—chronic obstructive pulmonary disease	0.000158	0.0297	CrCbGaD
Orphenadrine—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000158	0.0295	CrCbGaD
Orphenadrine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00178	CcSEcCtD
Orphenadrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00171	CcSEcCtD
Orphenadrine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00169	CcSEcCtD
Orphenadrine—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000141	0.0263	CrCbGaD
Orphenadrine—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.0263	CrCbGaD
Orphenadrine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000136	0.0016	CcSEcCtD
Orphenadrine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000132	0.0248	CrCbGaD
Orphenadrine—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.000129	0.0242	CrCbGaD
Orphenadrine—Phenprocoumon—ALB—chronic obstructive pulmonary disease	0.000111	0.0209	CrCbGaD
Orphenadrine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.000109	0.0204	CrCbGaD
Orphenadrine—Fluoxetine—ALB—chronic obstructive pulmonary disease	0.000108	0.0203	CrCbGaD
Orphenadrine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	0.000104	0.0194	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000102	0.0191	CrCbGaD
Orphenadrine—Warfarin—ALB—chronic obstructive pulmonary disease	9.89e-05	0.0185	CrCbGaD
Orphenadrine—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	9.84e-05	0.0184	CrCbGaD
Orphenadrine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	9.74e-05	0.0182	CrCbGaD
Orphenadrine—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	9.49e-05	0.0178	CrCbGaD
Orphenadrine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	9.46e-05	0.0177	CrCbGaD
Orphenadrine—Methadone—CYP1A2—chronic obstructive pulmonary disease	9.41e-05	0.0176	CrCbGaD
Orphenadrine—Promazine—CYP1A2—chronic obstructive pulmonary disease	8.4e-05	0.0157	CrCbGaD
Orphenadrine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	8.37e-05	0.0157	CrCbGaD
Orphenadrine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	8.08e-05	0.0151	CrCbGaD
Orphenadrine—Promethazine—HTR2A—chronic obstructive pulmonary disease	8.06e-05	0.0151	CrCbGaD
Orphenadrine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	8.03e-05	0.015	CrCbGaD
Orphenadrine—Doxepin—HTR2A—chronic obstructive pulmonary disease	7.98e-05	0.0149	CrCbGaD
Orphenadrine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	7.36e-05	0.0138	CrCbGaD
Orphenadrine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	7.31e-05	0.0137	CrCbGaD
Orphenadrine—Promazine—HTR2A—chronic obstructive pulmonary disease	7.09e-05	0.0133	CrCbGaD
Orphenadrine—Imipramine—HTR2A—chronic obstructive pulmonary disease	6.21e-05	0.0116	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	6.17e-05	0.0116	CrCbGaD
Orphenadrine—SCN4A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.94e-05	0.00174	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.77e-05	0.00167	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.77e-05	0.00167	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.74e-05	0.00166	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	4.7e-05	0.00165	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.68e-05	0.00164	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.62e-05	0.00162	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	4.58e-05	0.00161	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.56e-05	0.0016	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.55e-05	0.0016	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.54e-05	0.00159	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.53e-05	0.00159	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.53e-05	0.00159	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.46e-05	0.00157	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.41e-05	0.00155	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.00149	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.25e-05	0.00149	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.23e-05	0.00148	CbGpPWpGaD
Orphenadrine—Amitriptyline—ALB—chronic obstructive pulmonary disease	4.22e-05	0.00791	CrCbGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	4.2e-05	0.00148	CbGpPWpGaD
Orphenadrine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.00147	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.19e-05	0.00147	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.17e-05	0.00146	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.16e-05	0.00146	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.16e-05	0.00146	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	4.11e-05	0.00144	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.1e-05	0.00144	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.07e-05	0.00143	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.07e-05	0.00143	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.02e-05	0.00141	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.02e-05	0.00141	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.02e-05	0.00141	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4e-05	0.0014	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.97e-05	0.00139	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.94e-05	0.00138	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.9e-05	0.00137	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.9e-05	0.00137	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.89e-05	0.00137	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.78e-05	0.00133	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.74e-05	0.00131	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	3.68e-05	0.00129	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.00129	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.66e-05	0.00129	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.61e-05	0.00127	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.61e-05	0.00127	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.48e-05	0.00122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.46e-05	0.00122	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.00121	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.43e-05	0.0012	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.41e-05	0.0012	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.37e-05	0.00118	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.35e-05	0.00118	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.3e-05	0.00116	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.29e-05	0.00116	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.29e-05	0.00115	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.25e-05	0.00114	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.25e-05	0.00114	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	3.24e-05	0.00114	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.23e-05	0.00114	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.18e-05	0.00112	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	3.17e-05	0.00111	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.15e-05	0.0011	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.13e-05	0.0011	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.11e-05	0.00109	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.06e-05	0.00108	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.05e-05	0.00107	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.03e-05	0.00106	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.99e-05	0.00105	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.97e-05	0.00104	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.96e-05	0.00104	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.95e-05	0.00104	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.92e-05	0.00102	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.9e-05	0.00102	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.89e-05	0.00101	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.87e-05	0.00101	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.87e-05	0.00101	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.82e-05	0.000992	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.81e-05	0.000988	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.79e-05	0.000979	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.77e-05	0.000973	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.72e-05	0.000956	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.69e-05	0.000945	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.68e-05	0.000941	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.67e-05	0.000937	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.67e-05	0.000936	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.65e-05	0.000932	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.65e-05	0.000931	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.65e-05	0.00093	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.61e-05	0.000918	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.61e-05	0.000916	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.59e-05	0.000908	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.57e-05	0.000904	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.57e-05	0.000904	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.54e-05	0.00089	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.000884	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.49e-05	0.000876	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.49e-05	0.000876	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.49e-05	0.000874	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000872	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.45e-05	0.00086	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.4e-05	0.000843	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.39e-05	0.000839	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.37e-05	0.000832	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.36e-05	0.000829	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.36e-05	0.000829	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.35e-05	0.000826	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.35e-05	0.000824	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.34e-05	0.000823	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.33e-05	0.000819	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.32e-05	0.000813	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.32e-05	0.000813	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.29e-05	0.000803	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.28e-05	0.000801	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.21e-05	0.000775	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.21e-05	0.000775	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.19e-05	0.000769	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.17e-05	0.000762	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.14e-05	0.000753	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.13e-05	0.00075	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.11e-05	0.000739	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.1e-05	0.000738	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.000737	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.1e-05	0.000737	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.09e-05	0.000733	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.08e-05	0.000731	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.07e-05	0.000728	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.000727	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.000725	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.04e-05	0.000718	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—IL6—chronic obstructive pulmonary disease	2.04e-05	0.000717	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.04e-05	0.000716	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.01e-05	0.000708	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.01e-05	0.000706	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.01e-05	0.000705	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.94e-05	0.000681	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.93e-05	0.000679	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.000677	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.9e-05	0.000668	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.9e-05	0.000667	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.89e-05	0.000665	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.85e-05	0.000648	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.000642	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.81e-05	0.000635	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.8e-05	0.000634	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.000633	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.78e-05	0.000625	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.78e-05	0.000625	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000616	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.000591	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.67e-05	0.000588	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.66e-05	0.000583	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.66e-05	0.000583	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.66e-05	0.000581	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.63e-05	0.000572	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.62e-05	0.00057	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.59e-05	0.000558	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.56e-05	0.000549	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.55e-05	0.000545	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.5e-05	0.000526	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.47e-05	0.000518	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.47e-05	0.000517	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.46e-05	0.000511	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.36e-05	0.000478	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.00047	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.00047	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.000463	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.28e-05	0.00045	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.00045	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.28e-05	0.000448	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.26e-05	0.000443	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.000443	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.25e-05	0.000439	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000427	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.00042	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000411	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.15e-05	0.000405	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.0004	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000396	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000392	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000388	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.000374	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.000368	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000361	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000354	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.75e-06	0.000342	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.48e-06	0.000333	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.47e-06	0.000333	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.37e-06	0.000329	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.28e-06	0.000326	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.22e-06	0.000324	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.81e-06	0.00031	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.71e-06	0.000306	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.57e-06	0.000301	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.04e-06	0.000282	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.91e-06	0.000278	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.9e-06	0.000277	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.79e-06	0.000274	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.74e-06	0.000272	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.63e-06	0.000268	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.26e-06	0.000255	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.24e-06	0.000254	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.19e-06	0.000252	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.12e-06	0.00025	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.11e-06	0.00025	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.07e-06	0.000248	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.88e-06	0.000242	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.74e-06	0.000237	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.57e-06	0.000231	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.53e-06	0.000229	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.47e-06	0.000227	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.43e-06	0.000226	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.29e-06	0.000221	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.18e-06	0.000217	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.84e-06	0.000205	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.75e-06	0.000202	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.18e-06	0.000182	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.12e-06	0.00018	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.8e-06	0.000169	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.73e-06	0.000166	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.68e-06	0.000164	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.67e-06	0.000164	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.59e-06	0.000161	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.58e-06	0.000161	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.51e-06	0.000158	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.48e-06	0.000157	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.38e-06	0.000154	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.38e-06	0.000154	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.31e-06	0.000151	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.3e-06	0.000151	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.88e-06	0.000136	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.82e-06	0.000134	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.69e-06	0.00013	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.63e-06	0.000128	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.59e-06	0.000126	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.54e-06	0.000124	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.51e-06	0.000123	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.46e-06	0.000121	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.3e-06	0.000116	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.15e-06	0.000111	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.13e-06	0.00011	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.1e-06	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.89e-06	0.000102	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.85e-06	0.0001	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.84e-06	9.97e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.79e-06	9.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.38e-06	8.37e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.34e-06	8.23e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.18e-06	7.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.15e-06	7.54e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.13e-06	7.47e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.03e-06	7.14e-05	CbGpPWpGaD
